Kilitch Drugs (India) Limited (NSE:KILITCH)
India · Delayed Price · Currency is INR 185.86
+3.17 (1.74%)
Jun 19, 2026, 3:30 PM IST
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 6.48 billion as of June 18, 2026. Its market cap has decreased by -7.90% in one year.
Market Cap
6.48B
Enterprise Value
6.65B
Revenue
2.35B
Ranking
n/a
PE Ratio
21.48
Stock Price
185.86
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 6.48B, an increase of 45,100.88%. That is a compound annual growth rate of 28.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 6.48B | 14.81% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indoco Remedies | 21.69B |
| Beta Drugs | 20.09B |
| Sakar Healthcare | 17.88B |
| Windlas Biotech | 16.84B |
| Ind-Swift Laboratories | 16.25B |
| Jagsonpal Pharmaceuticals | 14.25B |
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |